Moreover, it is also worthwhile to investigate the therapeutic potential of TREM2 blockade in metastatic brain cancers or primary brain tumors, as these tumors might contain abundant TREM2-expressing microglia and monocyte-derived TAMs. Here, TREM2 is linked to brain neoplasm.